Ehring T, Böhm M, Heusch G
Department of Pathophysiology, University of Essen Medical School, Germany.
J Cardiovasc Pharmacol. 1992 Jul;20(1):63-74.
It is unclear whether the protective effects of calcium antagonists on reperfused myocardium are secondary to increased blood flow during ischemia (anti-ischemic action) or reperfusion (Gregg phenomenon), or are mediated through altered calcium kinetics in ischemic or reperfused myocardium. To study the effect of the calcium antagonist nisoldipine on the functional recovery of stunned myocardium, 32 enflurane-anesthetized dogs were subjected to 15 min of occlusion of the left circumflex coronary artery and subsequent 4 h of reperfusion. Eight dogs served as placebo controls (group I), and eight dogs received nisoldipine (5 micrograms/kg i.v.) before occlusion (group II), eight dogs at 10 min of occlusion (group III), and eight dogs at 4 min of reperfusion (group IV). The mean aortic pressure was kept constant with an intra-aortic balloon, and the heart rate did not change. In group I, posterior systolic wall thickening (WT, sonomicrometry) decreased from 18.3 +/- 2.4% (mean +/- SD) during control conditions to -3.0 +/- 2.0% at 13 min of occlusion. At 10 min of reperfusion, WT was 1.7 +/- 3.9% and did not recover further (-1.2 +/- 3.7% at 4 h of reperfusion). Posterior transmural blood flow (BF, colored microspheres) decreased from 1.42 +/- 0.43 ml/min/g during control conditions to 0.26 +/- 0.08 ml/min/g at 13 min of occlusion. BF was 2.07 +/- 0.93 ml/min/g at 10 min and 0.95 +/- 0.31 ml/min/g at 4 h of reperfusion. In groups III and IV, the WT and BF were not different from those in group I throughout the experimental protocol. In group II, however, the WT, although similar to the WT of group I before and during ischemia, recovered from 2.7 +/- 4.3% at 10 min to 11.8 +/- 6.0% at 4 h of reperfusion (p less than 0.05 vs. groups I, III, and IV). The BF in group II decreased from 2.52 +/- 0.66 ml/min/g after administration of nisoldipine to 0.22 +/- 0.14 ml/min g at 13 min of occlusion. The BF was 1.31 +/- 0.51 ml/min/g at 10 min and 1.33 +/- 0.43 ml/min/g at 4 h of reperfusion. Nisoldipine exerts no beneficial effect when given immediately before or after the onset of reperfusion. The improved functional recovery of reperfused myocardium in dogs pretreated with nisoldipine cannot be attributed to an increased regional myocardial blood flow during ischemia or reperfusion. The better myocardial recovery, therefore, appears to be related to an attenuated myocardial calcium overload during the first few minutes of ischemia.
钙拮抗剂对再灌注心肌的保护作用是继发于缺血期间(抗缺血作用)或再灌注期间(格雷格现象)血流量增加,还是通过缺血或再灌注心肌中钙动力学的改变介导,目前尚不清楚。为了研究钙拮抗剂尼索地平对顿抑心肌功能恢复的影响,对32只恩氟烷麻醉的犬进行左回旋支冠状动脉闭塞15分钟及随后4小时的再灌注。8只犬作为安慰剂对照(I组),8只犬在闭塞前给予尼索地平(5微克/千克静脉注射)(II组),8只犬在闭塞10分钟时给予(III组),8只犬在再灌注4分钟时给予(IV组)。用主动脉内球囊使平均主动脉压保持恒定,心率未发生变化。在I组中,收缩末期后壁增厚(WT,超声心动图测量)在对照条件下从18.3±2.4%(平均值±标准差)在闭塞13分钟时降至-3.0±2.0%。在再灌注10分钟时,WT为1.7±3.9%,且未进一步恢复(在再灌注4小时时为-1.2±3.7%)。后壁跨壁血流量(BF,彩色微球法)在对照条件下从1.42±0.43毫升/分钟/克在闭塞13分钟时降至0.26±0.08毫升/分钟/克。BF在再灌注10分钟时为2.07±0.93毫升/分钟/克,在再灌注4小时时为0.95±0.31毫升/分钟/克。在III组和IV组中,在整个实验过程中WT和BF与I组无差异。然而,在II组中,WT虽然在缺血前和缺血期间与I组相似,但从再灌注10分钟时的2.7±4.3%恢复到再灌注4小时时的11.8±6.0%(与I、III和IV组相比,p<0.05)。II组的BF在给予尼索地平后从2.52±0.66毫升/分钟/克在闭塞13分钟时降至0.22±0.14毫升/分钟/克。BF在再灌注10分钟时为1.31±0.51毫升/分钟/克,在再灌注4小时时为1.33±0.43毫升/分钟/克。在再灌注开始前或开始后立即给予尼索地平无有益作用。用尼索地平预处理的犬再灌注心肌功能恢复的改善不能归因于缺血或再灌注期间局部心肌血流量增加。因此,更好的心肌恢复似乎与缺血最初几分钟内心肌钙超载减轻有关。